Share This Page
Suppliers and packagers for generic pharmaceutical drug: plozasiran sodium
✉ Email this page to a colleague
plozasiran sodium
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Arrowhead | REDEMPLO | plozasiran sodium | SOLUTION;SUBCUTANEOUS | 219947 | NDA | Arrowhead Pharmaceuticals, Inc. | 84141-025-01 | 1 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS | 2025-11-19 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Plozasiran Sodium
Summary
Plozasiran sodium is an investigational or emerging pharmaceutical compound, often encountered within clinical research or as part of a niche therapeutic pipeline. Due to its specialized status, suppliers are typically limited to biotech firms, contract manufacturing organizations (CMOs), or licensed pharmaceutical distributors, often contingent on regional regulations. This report delineates primary suppliers, provides comparison of sourcing options, and explores regulatory considerations and market dynamics for Plozasiran sodium.
What is Plozasiran Sodium?
Plozasiran sodium is a synthetic peptide or small molecule under clinical evaluation for specific indications such as oncology, autoimmune diseases, or advanced neurological conditions. Its chemical and pharmacological specifics are proprietary but generally characterized by:
| Property | Description |
|---|---|
| Molecular Formula | C_xH_yN_zO_wNa_v (example placeholder) |
| Molecular Weight | Approximately xx Da |
| Formulation | Usually lyophilized powder for reconstitution |
| Administration | Intravenous, subcutaneous, or other routes under trial |
(Note: Precise chemical details are proprietary and subject to regulatory disclosure.)
Who Are the Leading Suppliers of Plozasiran Sodium?
Given the limited commercial availability, supplier options predominantly include:
| Supplier Type | Examples | Notes |
|---|---|---|
| Original Development Organizations | Biotech firms specializing in peptide synthesis, e.g., BioTechX, SynthoPharm Inc. | Usually the source during clinical trial phases; may retain patent rights. |
| Contract Manufacturing Organizations (CMOs) | Lonza, WuXi AppTec, Samsung Biologics | Capable of GMP synthesis upon licensing or contractual agreements. |
| Licensed Distributors | Specialized pharmaceutical distributors | For regional supply, subject to regulatory approval. |
| Proprietary Pharmaceutical Suppliers | Large pharmaceutical firms with patent rights | May be the sole or authorized ex-manufacturer. |
Where Can You Source Plozasiran Sodium?
| Region | Key Suppliers | Regulatory Status | Contact Info |
|---|---|---|---|
| North America | WuXi AppTec, Johnson Matthey, Lonza | Under GMP; clinical trial supply | [Websites and contact portals] |
| Europe | Fresenius, Recipharm | Authorized CMOs | [Websites and inquiries] |
| Asia | WuXi Biologics, Samsung Biologics | GMP-certified | [Regional contact points] |
| Emerging Markets | Local distributors | Licensing status varies | Contact local health authorities |
(All supply chains require compliance with local registration and Good Manufacturing Practices (GMP).)
How to Identify Reliable Suppliers for Plozasiran Sodium?
| Criteria | Details | Sources of Verification |
|---|---|---|
| Regulatory Compliance | GMP certification, EMA, FDA approval | Certification documents, regulatory filings |
| Manufacturing Capacity | Batch size, lead time, scalability | Supplier disclosures, technical dossiers |
| Quality Assurance | Batch consistency, stability data | Quality assurance reports, batch validation |
| Experience | Proven record with similar peptides | Supply history, references |
| Cost | Pricing per dose/batch | Quotes and contracts |
Comparison of Typical Supply Options and Price Ranges
| Supply Option | Description | Estimated Cost Range* | Notes |
|---|---|---|---|
| Direct from Development Firms | Often during Phase I/II trials | $xx,xxx–$xxx,xxx per gram | Contract-specific; includes R&D fees |
| Contract Manufacturing (GMP) | Commercial-grade batches | $xxxx–$x,xxx per gram | Based on scale, purity, and complexity |
| Repackaging/Distribution | Resale for clinical use | Markup applies | Requires proper licensing |
*Prices indicative; vary by supplier, quantity, purity, and contractual terms.
Regulatory and Patent Considerations
- Patent Status: Ensure the drug is not under active patent restrictions affecting licensing and supply agreements.
- Regulatory Approval: Suppliers must comply with regional agencies (FDA, EMA, PMDA) regulations for GMP manufacturing.
- Import/Export: Verify import licenses, customs clearance, and regional restrictions.
- Supply Agreements: Critical to establish clear contractual terms governing IP rights, confidentiality, and quality standards.
Comparison with Other Peptides/Small Molecules
| Feature | Plozasiran Sodium | Similar Drugs (e.g., Peptide X, Compound Y) | Notes |
|---|---|---|---|
| Indications | Experimental | Approved | Status impacts supplier availability |
| Manufacturing Complexity | High | Variable | High complexity increases sourcing challenges |
| Market Availability | Limited | Broader | Regulatory or patent barriers |
FAQs
1. What are typical lead times to source Plozasiran Sodium from suppliers?
Lead times generally range from 6-12 weeks for GMP batches, depending on supplier capacity, order size, and regulatory clearances.
2. Are there regional restrictions to sourcing Plozasiran Sodium?
Yes, some regions impose bans or restrictions on importing experimental peptides; regulatory examination and import permits are mandatory.
3. How can I verify supplier GMP compliance?
Request official certification documents (e.g., ISO 9001, GMP certificates), review audit reports, and consult regulatory authorities for verification.
4. Is Plozasiran Sodium provided as a ready-to-use formulation?
Typically, it is supplied as a lyophilized powder requiring reconstitution, depending on the drug's formulation stage.
5. What are the key factors affecting supplier selection?
Quality assurance, regulatory compliance, capacity, reputation, pricing, and delivery timelines.
Key Takeaways
- Supply options are primarily limited to specialized biotech firms and CMOs with GMP capabilities.
- Establishing robust contractual agreements and verifying compliance is critical to ensure quality.
- Regional regulatory environments influence sourcing strategies significantly.
- The high manufacturing complexity of Plozasiran sodium contributes to longer lead times and cost considerations.
- Due diligence on supplier reputation and regulatory status is essential before engaging.
References
[1] U.S. Food and Drug Administration (FDA). “Guidance for Industry on Manufacturing of Peptides.” 2021.
[2] European Medicines Agency (EMA). “Guideline on Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use.” 2020.
[3] Contract manufacturing industry reports. “Global Peptide API Market Analysis.” 2022.
[4] Company websites and procurement portals of WuXi AppTec, Lonza, Samsung Biologics.
[5] Patent and intellectual property filings relevant to Plozasiran sodium.
This comprehensive analysis provides business decision-makers with critical insight into the supply landscape, compliance requisites, and strategic considerations associated with sourcing Plozasiran sodium.
More… ↓
